References
- Murphy S, Peterson P, Iland H, Laszlo J. Experience of the Polycythemia Vera Study Group with essential thrombocythemia: a final report on diagnostic criteria, survival, and leukemic transition by treatment. Semin Hematol 1997; 34: 29–39
- Sterkers Y, Preudhomme C, Lai J L, Demory J L, Caulier M T, Wattel E, et al. Acute myeloid leukemia and myelodysplastic syndromes following essential thrombocythemia treated with hydroxyurea: high proportion of cases with 17p deletion. Blood 1998; 91: 616–622
- Bernasconi P, Boni M, Cavigliano P M, Calatroni S, Brusamolino E, Passamonti F, et al. Acute myeloid leukemia (AML) having evolved from essential thrombocythemia (ET): distinctive chromosome abnormalities in patients treated with pipobroman or hydroxyurea. Leukemia 2002; 16: 2078–2083
- Cortelazzo S, Finazzi G, Ruggeri M, Vestri O, Galli M, Rodeghiero F, et al. Hydroxyurea for patients with essential thrombocythemia and a high risk of thrombosis. N Engl J Med 1995; 332: 1132–1136
- Horiike S, Taniwaki M, Misawa S, Abe T. Chromosome abnormalities and karyotypic evolution in 83 patients with myelodysplastic syndrome and predictive value for prognosis. Cancer 1988; 62: 1129–1138
- Najfeld V. FISHing among myeloproliferative disorders. Semin Hematol 1997; 34: 55–63
- Finazzi G, Ruggeri M, Rodeghiero F, Barbui T. Second malignancies in patients with essential thrombocythaemia treated with busulphan and hydroxyurea: long-term follow-up of a randomized clinical trial. Br J Haematol 2000; 110: 577–583
- Third International Workshop on Chromosomes in Leukemia, 190: Report on Essential Thrombocythemia. Cancer Genet Cytogenet 1981; 4: 138–142
- Gibbons B, Lillington D M, Monard S, Young B D, Cheung K L, Lister T A, et al. Fluorescence in situ hybridisation studies to characterise complete and partial monosomy 7 in myeloid disorders. Genes Chromosomes Cancer 1994; 10: 244–249
- Flactif M, Lai J L, Preudhomme C, Fenaux P. Fluorescence in situ hybridization improves the detection of monosomy 7 in myelodysplastic syndromes. Leukemia 1994; 8: 1012–1018
- Mecucci C, Rege-Cambrin G, Michaux J L, Tricot G, Van den Berghe H. Multiple chromosomally distinct cell populations in myelodysplastic syndromes and their possible significance in the evolution of the disease. Br J Haematol 1986; 64: 699–706
- Benitez J, Carbonell F, Sanchez Fayos J, Heimpel H. Karyotypic evolution in patients with myelodysplastic syndromes. Cancer Genet Cytogenet 1985; 16: 157–167
- Renneboog B, Hansen V, Heimann P, De Mulder A, Jannsen F, Ferster A. Spontaneous remission in a patient with therapy-related myelodysplastic syndrome (t-MDS) with monosomy 7. Br J Haematol 1996; 92: 696–698
- Scheurlen W, Borkhardt A, Ritterbach J, Huppertz H I. Spontaneous hematological remission in a boy with myelodysplastic syndrome and monosomy 7. Leukemia 1994; 8: 1012–1018
- Estey E, Keating M J, Pierce S, Stass S. Change in karyotype between diagnosis and first relapse in acute myelogenous leukemia. Leukemia 1995; 9: 972–976